BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Strebel A, Bachmann F, Wernli M, Erb P. Tumor necrosis factor-related, apoptosis-inducing ligand supports growth of mouse mastocytoma tumors by killing tumor-infiltrating macrophages. Int J Cancer 2002;100:627-34. [DOI: 10.1002/ijc.10539] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
Number Citing Articles
1 Sag D, Ayyildiz ZO, Gunalp S, Wingender G. The Role of TRAIL/DRs in the Modulation of Immune Cells and Responses. Cancers (Basel) 2019;11:E1469. [PMID: 31574961 DOI: 10.3390/cancers11101469] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
2 Cheng W, Zhao Y, Wang S, Jiang F. Tumor necrosis factor-related apoptosis-inducing ligand in vascular inflammation and atherosclerosis: a protector or culprit? Vascul Pharmacol 2014;63:135-44. [PMID: 25451562 DOI: 10.1016/j.vph.2014.10.004] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.5] [Reference Citation Analysis]
3 Kemter E, Lieke T, Kessler B, Kurome M, Wuensch A, Summerfield A, Ayares D, Nagashima H, Baars W, Schwinzer R, Wolf E. Human TNF-related apoptosis-inducing ligand-expressing dendritic cells from transgenic pigs attenuate human xenogeneic T cell responses. Xenotransplantation 2012;19:40-51. [PMID: 22360752 DOI: 10.1111/j.1399-3089.2011.00688.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
4 Mace TA, Yamane N, Cheng J, Hylander BL, Repasky EA. The Potential of the Tumor Microenvironment to Influence Apo2L/TRAIL Induced Apoptosis. Immunological Investigations 2006;35:279-96. [DOI: 10.1080/08820130600745463] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
5 Londoño D, Marques A, Hornung RL, Cadavid D. IL-10 helps control pathogen load during high-level bacteremia. J Immunol 2008;181:2076-83. [PMID: 18641346 DOI: 10.4049/jimmunol.181.3.2076] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 1.6] [Reference Citation Analysis]
6 Herr I, Schemmer P, Büchler MW. On the TRAIL to therapeutic intervention in liver disease. Hepatology 2007;46:266-74. [PMID: 17596886 DOI: 10.1002/hep.21740] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 1.9] [Reference Citation Analysis]
7 Bron LP, Scolyer RA, Thompson JF, Hersey P. Histological expression of tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) in human primary melanoma. Pathology 2004;36:561-5. [DOI: 10.1080/00313020400011268] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
8 Jakóbisiak M, Lasek W, Gołab J. Natural mechanisms protecting against cancer. Immunol Lett 2003;90:103-22. [PMID: 14687712 DOI: 10.1016/j.imlet.2003.08.005] [Cited by in Crossref: 119] [Cited by in F6Publishing: 100] [Article Influence: 6.6] [Reference Citation Analysis]
9 Ji J, Wernli M, Buechner S, Erb P. Fas Ligand Downregulation with Antisense Oligonucleotides in Cells and in Cultured Tissues of Normal Skin Epidermis and Basal Cell Carcinoma. Journal of Investigative Dermatology 2003;120:1094-9. [DOI: 10.1038/jid.2003.13] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
10 Herbeuval J, Lambert C, Sabido O, Cottier M, Fournel P, Dy M, Genin C. Macrophages From Cancer Patients: Analysis of TRAIL, TRAIL Receptors, and Colon Tumor Cell Apoptosis. JNCI Journal of the National Cancer Institute 2003;95:611-21. [DOI: 10.1093/jnci/95.8.611] [Cited by in Crossref: 39] [Cited by in F6Publishing: 41] [Article Influence: 2.1] [Reference Citation Analysis]